CANAAN X L.P. Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CANAAN X L.P..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CANAAN X L.P.. CANAAN X L.P. is 10% Owner in Protagonist Therapeutics, Inc ($PTGX) and Director in Protagonist Therapeutics, Inc ($PTGX) and Director in Iterum Therapeutics plc ($ITRM) and 10% Owner in NextCure, Inc. ($NXTC) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA).

Latest Insider Trading Transactions of CANAAN X L.P.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, IDYA, ITRM, NXTC, PTGX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 28 2019	IDYA	IDEAYA Biosciences ...	CANAAN X L.P.	10% Owner	Option Exercise	C	0.00	602,549	0	0
May 28 2019	IDYA	IDEAYA Biosciences ...	CANAAN X L.P.	10% Owner	Option Exercise	C	0.00	1,658,164	0	0
May 28 2019	IDYA	IDEAYA Biosciences ...	CANAAN X L.P.	10% Owner	Buy	P	10.00	400,000	4,000,000	2,660,713	2.3 M to 2.7 M (+17.69 %)
May 28 2019	IDYA	IDEAYA Biosciences ...	CANAAN X L.P.	10% Owner	Buy	C	0.00	602,549	0	2,260,713	1.7 M to 2.3 M (+36.34 %)
May 28 2019	IDYA	IDEAYA Biosciences ...	CANAAN X L.P.	10% Owner	Buy	C	0.00	1,658,164	0	1,658,164	0 to 1.7 M
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Option Exercise	C	0.00	2,296,605	0	0
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Option Exercise	C	0.00	5,861,455	0	0
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Option Exercise	C	0.00	5,970,000	0	0
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Option Exercise	C	0.00	3,582,000	0	0
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Buy	P	15.00	50,000	750,000	2,254,442	2.2 M to 2.3 M (+2.27 %)
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Buy	C	0.00	285,867	0	2,204,442	1.9 M to 2.2 M (+14.90 %)
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Buy	C	0.00	729,599	0	1,918,575	1.2 M to 1.9 M (+61.36 %)
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Buy	C	0.00	743,110	0	1,188,976	445.9 K to 1.2 M (+166.67 %)
May 13 2019	NXTC	NextCure, Inc.	CANAAN X L.P.	10% Owner	Buy	C	0.00	445,866	0	445,866	0 to 445.9 K
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Option Exercise	C	0.00	229,660	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Option Exercise	C	0.00	275,446	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Option Exercise	C	0.00	721,408	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Buy	P	13.00	506,656	6,586,528	1,733,170	1.2 M to 1.7 M (+41.31 %)
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Buy	C	0.00	229,660	0	1,226,514	996.9 K to 1.2 M (+23.04 %)
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Buy	C	0.00	275,446	0	996,854	721.4 K to 996.9 K (+38.18 %)
May 30 2018	ITRM	Iterum Therapeutic ...	CANAAN X L.P.	Director	Buy	C	0.00	721,408	0	721,408	0 to 721.4 K
May 21 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	6.09	38,968	237,358	2,116,552	2.2 M to 2.1 M (-1.81 %)
May 16 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	6.46	29,441	190,071	2,155,520	2.2 M to 2.2 M (-1.35 %)
May 16 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	6.48	57,715	374,080	2,184,961	2.2 M to 2.2 M (-2.57 %)
May 16 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	6.37	77,591	494,224	2,242,676	2.3 M to 2.2 M (-3.34 %)
Mar 26 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.71	59,950	1,241,325	2,320,267	2.4 M to 2.3 M (-2.52 %)
Mar 22 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.62	4,759	98,133	2,380,217	2.4 M to 2.4 M (-0.20 %)
Mar 22 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.61	17,699	364,727	2,384,976	2.4 M to 2.4 M (-0.74 %)
Mar 22 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.61	17,060	351,538	2,402,675	2.4 M to 2.4 M (-0.71 %)
Mar 19 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.57	13,439	276,446	2,419,735	2.4 M to 2.4 M (-0.55 %)
Mar 19 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.51	6,926	142,063	2,433,174	2.4 M to 2.4 M (-0.28 %)
Mar 15 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.64	11,751	242,521	2,440,100	2.5 M to 2.4 M (-0.48 %)
Mar 15 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.77	200	4,154	2,451,851	2.5 M to 2.5 M (-0.01 %)
Mar 15 2018	PTGX	Protagonist Therap ...	CANAAN X L.P.	10% Owner	Sell	S	20.84	1,204	25,094	2,452,051	2.5 M to 2.5 M (-0.05 %)
Aug 16 2016	PTGX	Protagonist Therap ...	CANAAN X L.P.	Director	Option Exercise	C	0.00	27,113,877	0	0
Aug 16 2016	PTGX	Protagonist Therap ...	CANAAN X L.P.	Director	Buy	P	12.00	583,333	6,999,996	2,453,255	1.9 M to 2.5 M (+31.20 %)
Aug 16 2016	PTGX	Protagonist Therap ...	CANAAN X L.P.	Director	Buy	C	0.00	1,869,922	0	1,869,922	0 to 1.9 M

Page: 1